Parkway Wealth Management Group »

Heron Therapeutics shares owned by Parkway Wealth Management Group

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Parkway Wealth Management Group from 13F filings

Historical chart of Parkway Wealth Management Group investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Parkway Wealth Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Parkway Wealth Management Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $33k 25k 1.30

More positions owned by Parkway Wealth Management Group

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Etf Ser Solutions Defiance Quantum (QTUM)
Global X Fds Defense Tech Etf (SHLD)
Ishares Tr Msci Euro Fl Etf (EUFN)
Ishares Msci Italy Etf (EWI)
Ark Etf Tr Innovation Etf (ARKK)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Rus Mdcp Val Etf (IWS)
Ishares Tr Rus Md Cp Gr Etf (IWP)
Global X Fds Global X Uranium (URA)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Tips Bd Etf (TIP)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Spdr Series Trust State Street Spd (SPYG)

View all positions for Parkway Wealth Management Group

Top funds holding Heron Therapeutics

Rubric Capital Management
Adage Capital Partners GP
BlackRock
Vanguard Group
Clearline Capital
Velan Capital Investment Management
Palisade Capital Management
Tejara Capital
Baker Bros. Advisors
Geode Capital Management
JW Asset Management
State Street Corporation
Tang Capital Management
D. E. Shaw & Co
Congress Park Capital

View all funds holding Heron Therapeutics